Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660.
Ajani JA, D’Amico TA, Bentrem DJ, Chao J, Cooke D, Corvera C, et al. Gastric cancer, version 2.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2022;20(2):167–92. https://doi.org/10.6004/jnccn.2022.0008.
Cai J, Qian K, Zuo X, Yue W, Bian Y, Yang J, et al. PLGA nanoparticle-based docetaxel/LY294002 drug delivery system enhances antitumor activities against gastric cancer. J Biomater Appl. 2019;33(10):1394–406. https://doi.org/10.1177/0885328219837683.
Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, Znaor A, et al. Cancer statistics for the year 2020: An overview. Int J Cancer. 2021;149(4):778–89. https://doi.org/10.1002/ijc.33588.
Li Y, Wang Z, Gao P, Cao D, Dong R, Zhu M, et al. CircRHBDD1 promotes immune escape via IGF2BP2/PD-L1 signaling and acts as a nanotherapeutic target in gastric cancer. J Transl Med. 2024;22(1):704. https://doi.org/10.1186/s12967-024-05498-9.
Article PubMed PubMed Central Google Scholar
Sitarz R, Skierucha M, Mielko J, Offerhaus GJA, Maciejewski R, Polkowski WP. Gastric cancer: epidemiology, prevention, classification, and treatment. Cancer Manag Res. 2018. https://doi.org/10.2147/CMAR.S149619.
Article PubMed PubMed Central Google Scholar
Afrin H, Esquivel SV, Kumar R, Zahid MI, Oporeza B, Rahman MF, et al. β-glucan-mediated oral codelivery of 5FU and Bcl2 siRNA attenuates stomach cancer. ACS Appl Mater Interfaces. 2023;15(27):32188–200. https://doi.org/10.1021/acsami.3c03528.
Article PubMed PubMed Central Google Scholar
Huang H-L, Chen K-W, Liao H-W, Wang L-Y, Peng S-L, Lai C-H, et al. Nanoparticles for augmenting therapeutic potential and alleviating the effect of Di (2-ethylhexyl) phthalate on gastric cancer. ACS Appl Mater Interfaces. 2024;16(15):18285–99. https://doi.org/10.1021/acsami.3c15976.
Article PubMed PubMed Central Google Scholar
Gu E, Song W, Liu A, Wang H. SCDb: an integrated database of stomach cancer. BMC Cancer. 2020;20:1–10. https://doi.org/10.1186/s12885-020-06869-3.
Hotchkiss KA, Ashton AW, Mahmood R, Russell RG, Sparano JA, Schwartz EL. Inhibition of endothelial cell function in vitro and angiogenesis in vivo by docetaxel (Taxotere): association with impaired repositioning of the microtubule organizing center. Mol Cancer Ther. 2002;1(13):1191–200.
Zhang E, Xing R, Liu S, Li K, Qin Y, Yu H, et al. Vascular targeted chitosan-derived nanoparticles as docetaxel carriers for gastric cancer therapy. Int J Biol Macromol. 2019;126:662–72. https://doi.org/10.1016/j.ijbiomac.2018.12.262.
Zheng D, Li D, Lu X, Feng Z. Enhanced antitumor efficiency of docetaxel-loaded nanoparticles in a human ovarian xenograft model with lower systemic toxicities by intratumoral delivery. Oncol Rep. 2010;23(3):717–24. https://doi.org/10.3892/or_00000689.
Engels FK, Mathot RA, Verweij J. Alternative drug formulations of docetaxel: a review. Anticancer Drugs. 2007;18(2):95–103. https://doi.org/10.1097/CAD.0b013e3280113338.
Alavi SE, Alharthi S, Alavi SZ, Raza A, Shahmabadi HE. Bioresponsive drug delivery systems. Drug Discov Today. 2024;29(1):103849. https://doi.org/10.1016/j.drudis.2023.103849.
Alavi SE, Alharthi S, Alavi SF, Alavi SZ, Zahra GE, Raza A, et al. Microfluidics for personalized drug delivery. Drug Discov Today. 2024;29(4):103936. https://doi.org/10.1016/j.drudis.2024.103936.
Alavi SE, Cabot PJ, Yap GY, Moyle PM. Optimized methods for the production and bioconjugation of site-specific, alkyne-modified glucagon-like peptide-1 (GLP-1) analogs to azide-modified delivery platforms using copper-catalyzed alkyne–azide cycloaddition. Bioconjug Chem. 2020;31(7):1820–34. https://doi.org/10.1021/acs.bioconjchem.0c00291.
Alavi SE, Cabot PJ, Moyle PM. Glucagon-like peptide-1 receptor agonists and strategies to improve their efficiency. Mol Pharm. 2019;16(6):2278–95. https://doi.org/10.1021/acs.molpharmaceut.9b00308.
Alavi SE, Shahmabadi HE. GLP-1 peptide analogs for targeting pancreatic beta cells. Drug Discov Today. 2021;26(8):1936–43. https://doi.org/10.1016/j.drudis.2021.03.032.
Alavi SE, Panah N, Page F, Gholami M, Dastfal A, Sharma LA, et al. Hydrogel-based therapeutic coatings for dental implants. Eur Polym J. 2022;181:111652. https://doi.org/10.1016/j.eurpolymj.2022.111652.
Shahmabadi HE, Doun SKB, Alavi SE, Mortazavi M, Saffari Z, Farahnak M, et al. An investigation into the parameters affecting preparation of polybutyl cyanoacrylate nanoparticles by emulsion polymerization. Indian J Clin Biochem. 2014;29(3):357–61. https://doi.org/10.1007/s12291-013-0325-0.
Alavi SE, Cabot PJ, Raza A, Moyle PM. Developing GLP-1 conjugated self-assembling nanofibers using copper-catalyzed alkyne–azide cycloaddition and evaluation of their biological activity. Bioconjug Chem. 2021;32(4):810–20. https://doi.org/10.1021/acs.bioconjchem.1c00091.
Yaghoubi F, Motlagh NSH, Naghib SM, Haghiralsadat F, Jaliani HZ, Moradi A. A functionalized graphene oxide with improved cytocompatibility for stimuli-responsive co-delivery of curcumin and doxorubicin in cancer treatment. Sci Rep. 2022;12(1):1959. https://doi.org/10.1038/s41598-022-05793-9.
Article PubMed PubMed Central Google Scholar
Alavi SE, Alavi SF, Koohi M, Raza A, Ebrahimi H, Shahmabadi. Nanoparticle-integrated metal–organic frameworks: a revolution in next-generation drug delivery systems. J Pharm Investig. 2024. https://doi.org/10.1007/s40005-024-00691-w.
Li H, Wang S, Yang Z, Meng X, Niu M. Nanomaterials modulate tumor-associated macrophages for the treatment of digestive system tumors. Bioact Mater. 2024;36:376–412. https://doi.org/10.1016/j.bioactmat.2024.03.003.
Article PubMed PubMed Central Google Scholar
He C, Chan C, Weichselbaum RR, Fleming GF, Yamada SD, Lin W. Nanomedicine for combination therapy of cancer. EBioMedicine. 2015;2(5):366–7. https://doi.org/10.1016/j.ebiom.2015.05.013.
Article PubMed PubMed Central Google Scholar
Miao L, Daozhou L, Ying C, Qibing M, Siyuan Z. A resveratrol-loaded nanostructured lipid carrier hydrogel to enhance the anti-UV irradiation and anti-oxidant efficacy. Colloids Surf B Biointerfaces. 2021;204:111786. https://doi.org/10.1016/j.colsurfb.2021.111786.
Lakhani P, Patil A, Wu K-W, Sweeney C, Tripathi S, Avula B, et al. Optimization, stabilization, and characterization of amphotericin B loaded nanostructured lipid carriers for ocular drug delivery. Int J Pharm. 2019;572:118771. https://doi.org/10.1016/j.ijpharm.2019.118771.
Article PubMed PubMed Central Google Scholar
Sadaquat H, Akhtar M, Nazir M, Ahmad R, Alvi Z, Akhtar N. Biodegradable and biocompatible polymeric nanoparticles for enhanced solubility and safe oral delivery of docetaxel: In vivo toxicity evaluation. Int J Pharm. 2021;598:120363. https://doi.org/10.1016/j.ijpharm.2021.120363.
Yusefi M, Lee-Kiun MS, Shameli K, Teow S-Y, Ali RR, Siew K-K, et al. 5-Fluorouracil loaded magnetic cellulose bionanocomposites for potential colorectal cancer treatment. Carbohydr Polym. 2021;273:118523. https://doi.org/10.1016/j.carbpol.2021.118523.
Park YI, Kwon S-H, Lee G, Motoyama K, Kim MW, Lin M, et al. pH-sensitive multi-drug liposomes targeting folate receptor β for efficient treatment of non-small cell lung cancer. J Control Release. 2021;330:1–14. https://doi.org/10.1016/j.jconrel.2020.12.011.
Alavi SE, Raza A, Esfahani MKM, Akbarzadeh A, Abdollahi SH, Shahmabadi HE. Carboplatin niosomal nanoplatform for potentiated chemotherapy. J Pharm Sci. 2022;111(11):3029–37. https://doi.org/10.1016/j.xphs.2022.06.002.
留言 (0)